Fundraising FoxTeraImmune
Germantown, US · Founded 2019 · Delaware corporation
Find your way into TeraImmune
Sign up to see every warm intro you have to TeraImmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TeraImmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TeraImmune was founded in 2019 by Yong Chan Kim, PhD.
YC
Yong Chan Kim, PhDFounder
JP
Jihoon ParkNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2022
▶$3MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jihoon ParkExecutive Officer, Director
- Yong Chan Kim, PhDExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded TeraImmune?
- TeraImmune was founded by Yong Chan Kim, PhD in 2019.
- How much funding has TeraImmune raised?
- TeraImmune has disclosed $3M raised across 1 round.
- Where is TeraImmune headquartered?
- TeraImmune is headquartered in Germantown, US.